BeOne Medicines AG (6160.HK) HKSE

221.40

-7.6(-3.32%)

Updated at November 14 02:10PM

Currency In HKD

Valuation

Market Cap19.23B
Enterprise Value17.69B
P/E Ratio-226.11
PEG Ratio-4.1
Price/Sales Ratio9
Price/Book Ratio10.65
Enterprise/Revenue8.62
Enterprise/EBITDA440.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.04
Operating Margin-0.02

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.05

Income Statement

Revenue3.81B
Revenue/Share3.24
Gross Profit3.22B
EBITDA-396.44M
Net Income-644.79M
Diluted EPS-0.47

Balance Sheet

Total Cash2.76B
Total Cash/Share1.96
Total Debt1.03B
Total Debt/Equity0.27
Current Ratio1.95
Book Value Per Share2.68

Price History

52-Week Change86.22
52-Week High229.4
52-Week Low103.1
Moving Average 50 Days196.29
Moving Average 200 Days166.61

Statistics

Average Volume5.8M
Shares Outstanding1.44B
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.08
Last Split FactorN/A
Last Split DateN/A